A Phase I, randomized, double-blind, placebo-controlled trial of a Reprna-based vaccine for Covid-19: A brief analysis of safety in adults

Authors

• Bruna Machado, SENAI CIMATEC, BrazilFollow
• Katharine Hodel, SENAI/CIMATEC University Center, Brazil
• Camila Valente, Larissa Fonseca, SENAI/CIMATEC University Center, Brazil
• Milena Soares, Larissa Fonseca, SENAI/CIMATEC University Center, Brazil

Conference Dates

May 19 - 24, 2024

Abstract

Please click Additional Files below to see the full abstract.

Recommended Citation

Bruna Machado, Katharine Hodel, Camila Valente, and Milena Soares, "A Phase I, randomized, double-blind, placebo-controlled trial of a Reprna-based vaccine for Covid-19: A brief analysis of safety in adults" in "Vaccine Technology IX", Linda Lua, The University of Queensland, Australia; Charles Lutsch, Sanofi-Vaccines, France; Francesc Gòdia, Universitat Autònoma de Barcelona (UAB), Spain; Tara Tagmyer, CMC Leader, USA Eds, ECI Symposium Series, (2024). https://dc.engconfintl.org/vaccine_ix/47